Alpine Immune Sciences to Report Second Quarter 2021 Financial Results and to Present at Upcoming Investor Conferences
Alpine Immune Sciences (NASDAQ:ALPN) will release its second quarter 2021 financial results on August 10, 2021, after market close. A conference call and webcast will be held at 4:30 p.m. ET to discuss the results and provide a corporate update. Additionally, the company will participate in the Bernstein CD28 Day on August 9 and the Wedbush PacGrow Healthcare Virtual Conference on August 11. The company focuses on developing innovative immunotherapies for cancer and autoimmune diseases, supported by strategic collaborations and a diverse pipeline.
- Upcoming release of financial results may attract investor interest.
- Participation in multiple investor events suggests active engagement with stakeholders.
- Diverse pipeline of clinical and preclinical candidates indicates strong growth potential.
- None.
Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced the company will release second quarter 2021 financial results on Tuesday, August 10, 2021 after the close of market. Alpine will host a corresponding conference call and live webcast at 4:30 p.m. ET/1:30 p.m. PT on the same day to discuss the results and provide a corporate update.
Company management will also present at the following upcoming investor events and conferences:
-
Bernstein CD28 Day
Presentation: Monday, August 9, 12:15 p.m. ET (9:15 a.m. PT)
Following the presentation, the presented materials from the Bernstein CD28 Day will be available under “Events & Presentations” portion of the Investors section of the company website.
-
2021 Wedbush PacGrow Healthcare Virtual Conference
For Your IOnly - Progress, Challenges in Immuno-Oncology Panel: Wednesday, August 11, 12:35 p.m. ET (9:35 a.m. PT)
Second Quarter 2021 Financial Results Conference Call and Webcast Details
To access the live call by phone, dial (800) 816-3005 (domestic) or (857) 770-0069 (international) and reference conference ID: 8145346. A live webcast of the presentation will be available online in the investor relations section of the company’s website at https://ir.alpineimmunesciences.com/events. A replay of the presentation will be available on the company website for 90 days following the webcast.
About Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on Twitter and LinkedIn.
Source: Alpine Immune Sciences Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210804005449/en/
FAQ
When will Alpine Immune Sciences release its second quarter 2021 financial results?
What time is the conference call for the second quarter 2021 financial results?
What events will Alpine Immune Sciences participate in during August 2021?
How can I access the webcast of the second quarter 2021 financial results?
